Compare CARR & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CARR | HLN |
|---|---|---|
| Founded | 2019 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Package Goods/Cosmetics |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.3B | 43.7B |
| IPO Year | N/A | N/A |
| Metric | CARR | HLN |
|---|---|---|
| Price | $60.69 | $10.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $71.75 | N/A |
| AVG Volume (30 Days) | ★ 8.2M | 8.1M |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | 1.59% | ★ 1.72% |
| EPS Growth | 17.82 | ★ 41.64 |
| EPS | ★ 4.55 | 0.23 |
| Revenue | ★ $22,058,000,000.00 | $15,096,588,575.00 |
| Revenue This Year | N/A | $1.51 |
| Revenue Next Year | $3.14 | $4.67 |
| P/E Ratio | ★ $13.27 | $22.32 |
| Revenue Growth | ★ 1.87 | N/A |
| 52 Week Low | $50.24 | $8.71 |
| 52 Week High | $81.09 | $11.42 |
| Indicator | CARR | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 72.77 | 64.01 |
| Support Level | $55.59 | $10.26 |
| Resistance Level | $58.43 | $10.57 |
| Average True Range (ATR) | 1.36 | 0.16 |
| MACD | 0.45 | 0.03 |
| Stochastic Oscillator | 92.59 | 92.53 |
Carrier Global provides HVAC and refrigeration products and services that serve the global residential, commercial, and transportation markets. The company's HVAC businesses account for approximately 85% of consolidated revenue, with residential and light commercial HVAC and commercial HVAC representing about 60% and 25% of total revenue, respectively. Carrier's refrigeration segment, which accounts for approximately 15% of consolidated revenue, consists of its transportation refrigeration and Sensitech supply chain monitoring products and services.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.